A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)
Clinical trial NCT04907851 · COMPLETED
Trial details
- NCT number
- NCT04907851
- Sponsor
- Redx Pharma Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-10
- Primary completion
- 2023-11-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.